Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 114, Issue 4, 2002, Pages 446-449

  Tang, Guomei ^a   Xie, Huijun ^a   Xu, Lin ^a   Hao, Yixin ^a   Lin, Dayu ^a   Ren, Daming ^a,b  

^a FUDAN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Alpha 1 antichymotrypsin; Apolipoprotein E gene; Parkinson disease; Polymorphism

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN E; SIGNAL PEPTIDE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHINA; CONTROLLED STUDY; DEGENERATIVE DISEASE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AGED; ALPHA 1-ANTICHYMOTRYPSIN; APOLIPOPROTEINS E; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 0037042066     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.10249     Document Type: Article

References (27)

1. Neurogenetic correlates of Parkinson disease: Apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism
2. Is idiopathic parkinsonism the consequence of an event or a process?
3. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer disease enrolled in the CERAD study. Consortium to establish a registry for Alzheimer disease
4. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer disease in late onset families
5. The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson disease
6. The α1-antichymotrypsin A-allele in German Parkinson disease patients
7. APOE and the risk of PD with or without dementia in a population-based study
8. History of dementia and Parkinson disease in first degree relatives of patients with Alzheimer disease
9. The consortium to establish a registry for Alzheimer disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson features in Alzheimer disease
10. Apolipoprotein E4 in Parkinson disease and dementia: New data and meta-analysis of published studies
11. APOE*4-associated Alzheimer disease risk is modified by alpha1-antichymotrypsin polymorphism
12. Substantia nigra lesions in Alzheimer disease and normal aging
13. Apolipoprotein E genotypes in Parkinson disease with and without dementia
14. Increased susceptibility to sporadic Parkinson disease by a certain combined alpha-synuclein/apolipoprotein E genotype
15. The occurrence of lung cancer in man
16. Risk of Alzheimer disease in relatives of Parkinson disease patients with and without dementia
17. Heterogeneity in dementia of the Alzheimer type: Evidence of subgroups
18. Calculating confidence intervals for relative risks (odds ratios) and standardized ratios and rates
19. Alpha1-antichymotrypsin gene polymorphism and susceptibility to Parkinson disease
20. Apolipoprotein E polymorphisms and Parkinson disease
21. Alzheimer disease and Parkinson disease: Distinct entities or extremes of a spectrum of neurodegeneration?
22. Genetic dissection of familial Parkinson disease
23. Genetic association study between alpha-1 antichymotrypsin polymorphism and Alzheimer disease in Chinese Han population
24. Genetic association analysis of α-1-antichymotrypsin polymorphism in Parkinson disease
25. On estimating the relation between blood group and disease
26. Genetic association between susceptibility to Parkinson disease and alpha1-antichymotrypsin polymorphism
27. Modulation of the age at onset of Parkinson disease by apolipoprotein E genotypes